These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2250943)

  • 41. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
    Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
    Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance and detection of insulin-like growth factor I in vitreous with proliferative retinal diseases by radioimmunoassay].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):122-5. PubMed ID: 7656720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of growth hormone in proliferative diabetic retinopathy. Clinical and immunohistochemical aspects].
    Negre F; Fredj-Reygrobellet D; Harroche S; Taieb JC
    Ophtalmologie; 1990; 4(1):56-9. PubMed ID: 2250943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The growth hormone hypothesis - 2005 revision.
    Frystyk J
    Horm Metab Res; 2005 Apr; 37 Suppl 1():44-8. PubMed ID: 15918110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.